HALO logo
halo search icon
Lisata Therapeutics, Inc.
Lisata Therapeutics, Inc.
LSTA · NAS

Lisata Therapeutics, Inc.

US$3.14

Price Arrow-0.04 (-1.258%)
21/05/2026 04:00:01 PM
All-CompaniesAll-ConsensusHALO AllHammer BearishRecent Earnings downgrade
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Lisata Therapeutics, Inc. Overview

LSTA Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Neutral

Earnings

Very Weak

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About LSTA

icon

Telephone

1.908.842.0100

icon

Address

2nd floor, 110 Allen Road, Basking Ridge, NJ 07920

Description

Lisata Therapeutics, Inc. is a clinical-stage pharmaceutical company, which engages in the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other major diseases. Its product, Certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered anti-cancer drugs to target and penetrate tumors. The company was founded in 1980 and is headquartered in Basking Ridge, NJ.

LSTA Price Chart

Key Stats

Market Cap

US$28.96M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 1.81 - 5.07

Trade Value (12mth)

US$71,374.00

1 week

0.32%

1 month

-7.02%

YTD

62.24%

1 year

26.69%

All time high

51000.00

Key Fundamentals

EPS 3 yr Growth

-81.80%

EBITDA Margin

NaN%

Operating Cashflow

-$16m

Free Cash Flow Return

-71.80%

ROIC

-74.70%

Interest Coverage

0.00

Quick Ratio

5.80

Other Data

Shares Outstanding (Fully Diluted)

9m

HALO Sector

Healthcare

Next Company Report Date

26-Feb-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

LSTA Announcements

Latest Announcements

DateAnnouncements
12 May 26
12 May 26
12 May 26
05 May 26
04 May 26

LSTA Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-2.58-2.4-1.91locklocklock
EPS (Fully Diluted)
$locklocklocklock-2.58-2.4-1.91locklocklock
Growth
%locklocklocklock75.37.120.4locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Lisata Therapeutics, Inc. (LSTA:NAS)?
Halo FAQ
The current share price of Lisata Therapeutics, Inc. (LSTA:NAS) is USD$3.14.
What is the 52-week high share price for Lisata Therapeutics, Inc. (LSTA:NAS)?
Halo FAQ
The 52-week high share price for Lisata Therapeutics, Inc. (LSTA:NAS) is USD$5.07.
What is the 52-week low share price for Lisata Therapeutics, Inc. (LSTA:NAS)?
Halo FAQ
The 52-week low share price for Lisata Therapeutics, Inc. (LSTA:NAS) is USD$1.81.
What is the dividend yield for Lisata Therapeutics, Inc. (LSTA:NAS)?
Halo FAQ
Lisata Therapeutics, Inc. (LSTA:NAS) does not pay a dividend.
What was Lisata Therapeutics, Inc. (LSTA:NAS) last dividend payment?
Halo FAQ
Lisata Therapeutics, Inc. (LSTA:NAS) does not pay a dividend.
What is the franking level for Lisata Therapeutics, Inc. (LSTA:NAS)?
Halo FAQ
Lisata Therapeutics, Inc. (LSTA:NAS) has a franking level of 0.00%.
In which sector is Lisata Therapeutics, Inc. (LSTA:NAS) classified?
Halo FAQ
Lisata Therapeutics, Inc. (LSTA:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.